Welcome to the 2014 Accomplishments Report of the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The Ohio State University’s cancer program, embodied in both our OSUCCC and The James, is working to create a cancer-free world, one person, one discovery at a time. We strive to eradicate cancer by integrating groundbreaking research with personalized patient care and excellence in education.
This report offers a glance at some of our notable achievements and activities of 2014 as we continued pursuing our vision of a world without cancer.
From the Director/CEO
In the galaxy of stellar years for Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), none burn brighter than 2014.
Not only did we open our transformational new cancer hospital—a striking 21-story structure that ranks among the most advanced in the world—but we also furthered our groundbreaking research that is translating discoveries to innovative and compassionate patient care.
And to support our research in a time of dwindling federal grant money, we once again teamed up with a caring community to push our annual grassroots Pelotonia bicycle tour to new heights of participation and fundraising success.
Our 2014 OSUCCC – James Accomplishments Report highlights our new hospital and some of its many sophisticated features, then offers a glimpse at a few of our many notable research achievements, including work that greatly contributed to U.S. Food and Drug Administration approval of the drug ibrutinib for treating certain patients with chronic lymphocytic leukemia.
You can also read in this report about:
- large grants we received in the past year from the National Cancer Institute;
- our latest successes in recruiting some of the top minds in cancer care to Ohio State;
- prestigious awards earned by our medical scientists and administrators;
- initiatives such as our partnership with Moffitt Cancer Center in Tampa, Fla., to form the Oncology Research Information Exchange Network (ORIEN), which is likely the largest collaboration of its kind to accelerate discoveries in cancer research;
- the astounding success of Pelotonia 14 and how it boosted our six-year fundraising total for this highly popular event to more than $82 million, every cent of which goes to cancer research at the OSUCCC – James thanks to the event’s generous sponsors
In summary, 2014 was a banner year punctuated by the exciting Dec. 15 opening of our new hospital less than a quarter century after the opening of the original James in 1990.
Just as there are no routine cancers because each case is biologically unique, the new James is no routine cancer hospital. It was designed to bring our more than 300 researchers—who collectively represent 12 of the 14 colleges at The Ohio State University—into closer working proximity than ever before with our many oncology subspecialists in a “precision cancer medicine” model that uses genomic technologies to aid each patient’s diagnosis and treatment. This personalized approach is expediting our quest to create a cancer-free world.
Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, The James Cancer Hospital and Solove Research Institute
John L. Marakas Nationwide Insurance Enterprise Foundation Chair in Cancer Research